1034975-62-6

4-(4-methylpiperazin-1-yl)-2-[(tetrahydropyran-4-yl)(2,2,2-trifluoroacetyl)amino]benzoic acid trifluoroacetateis an intermediate of Entrectinib which is used to treat a certain type of non-small cell lung cancer (NSCLC) in adults that has spread to other parts of the body.